CTL Attenuation Regulated by PS1 in Cancer-Associated Fibroblast-Reference-Cited by-同舟云学术

CTL Attenuation Regulated by PS1 in Cancer-Associated Fibroblast

Published:2020-06-10 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Zhang Hongyu,Jiang Rong,Zhou Jinhua,Wang Juan,Xu Yuejuan,Zhang He,Gu Yanzheng,Fu Fengqing,Shen Yu,Zhang Guangbo,Feng Lanlan,Zhang Xueguang,Chen Youguo,Shen Fangrong

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference20 articles.

1. Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes;Stumpf;Br J Cancer.,2009

2. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma;Ene-Obong;Gastroenterology.,2013

3. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;N Engl J Med.,2013

4. Overall survival and long-term safety of nivolumab (Anti-programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non-small-cell lung cancer;Gettinger;J Clin Oncol.,2015

5. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N Engl J Med.,2012

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential;Upsala Journal of Medical Sciences;2024-05-24

2. Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8+ T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine-learning bioinformatics retrospective study;International Journal of Surgery;2024-05-17

3. Cancer-associated fibroblasts in neoadjuvant setting for solid cancers;Critical Reviews in Oncology/Hematology;2024-01

4. Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy;MedComm;2023-12

5. Epithelial Ovarian Cancer: Microenvironment and Immunecheck Point Inhibitors;European Journal of Medical and Health Sciences;2023-10-16